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ABSTRACT 
BACKGROUND:	In non-diabetic patients, HbA1C could be utilised for risk 
stratification of CAD and its severity; independent of traditional cardiovascular risk 
factors. 
OBJECTIVES : To determine the association between both acute hyperglycemia  or 
stress hyperglycemia  if present , that is denoted by the admission blood glucose at the 
time of presentation  and chronic hyperglycemia which is denoted by HbA1c   and 
short term clinical outcome in non-diabetic patients with STEMI. 
METHOD: Fifty non-diabetic patients admitted in the intensive care medicine unit 
with acute ST elevation MI, treated with fibrinolysis were included in the study.  
HbA1C was done along with other routine investigations. Echocardiogram was done 
for all the patients. They were followed up during the whole days of hospital stay and 
were watched for any complications. 
RESULTS:	The complications of STEMI were found more in Abnormal HbA1c 
group (OR 4.84). Cardiogenic shock found more in diabetic group (OR 12.27). 
Abnormal admission RBS did not correlate significantly with STEMI complications. 
CONCLUSION: HbA1c should be availed for all patients presenting with STEMI 
regardless of previous glycemic status. It predicts the complications of STEMI unlike 
admission RBS.  
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